PLUS THERAPEUTICS, INC. — Director's Dealing 2011

Jan 31, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2011-01-27

Reporting Person: HEDRICK MARC H (Director, President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-01-27	Employee Stock Option (Right to Buy)	$5.57	A	55000	Acquired	2021-01-27	Common Stock (55000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	448238	Direct
Common Stock	4000	Indirect
Common Stock	7800	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrant to Purchase Common Stock	$2.62	2014-05-12	Common Stock (35000)	35000	Direct

Footnotes

F1: The Employee Stock Options vest 1/48th each month from date of grant.